Nektar Therapeutics
0.90
0.00 (0.00%)
At close: Jan 15, 2025, 3:59 PM
0.88
-2.60%
After-hours Jan 15, 2025, 04:00 PM EST

Nektar Therapeutics Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
License Collaboration And Other Revenue Revenue 378.00K 97.00K 341.00K 155.00K 9.00K 15.00K 17.00K 314.00K 9.00K 1.57M 40.00K 314.00K 28.00K 54.00K 428.00K 1.63M 26.27M 27.52M 7.12M 3.12M 2.54M 4.20M 8.97M 8.37M 9.04M
License Collaboration And Other Revenue Revenue Growth +289.69% -71.55% +120.00% +1622.22% -40.00% -11.76% -94.59% +3388.89% -99.43% +3832.50% -87.26% +1021.43% -48.15% -87.38% -73.76% -93.79% -4.51% +286.72% +127.97% +23.12% -39.70% -53.14% +7.15% -7.44% n/a
Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue 15.73M 15.51M 18.06M 18.17M 15.83M 16.86M 17.63M 18.34M 16.26M 17.56M 19.08M 19.41M 20.46M 18.80M 20.56M 10.42M 7.68M 9.89M 8.72M 10.26M 9.09M 8.23M n/a n/a n/a
Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue Growth +1.44% -14.14% -0.58% +14.75% -6.10% -4.35% -3.90% +12.78% -7.39% -7.96% -1.72% -5.10% +8.82% -8.58% +97.29% +35.63% -22.34% +13.50% -15.06% +12.90% +10.46% n/a n/a n/a n/a
Product Revenue 8.02M 6.03M 5.48M 5.82M 4.66M 4.72M 4.38M 4.97M 5.31M 5.69M 5.89M 5.19M 7.85M 4.79M 2.88M 5.69M 5.49M 3.44M 5.82M 5.56M 4.35M 4.40M n/a n/a n/a
Product Revenue Growth +32.83% +10.05% -5.82% +24.99% -1.27% +7.74% -11.87% -6.46% -6.61% -3.43% +13.40% -33.80% +63.63% +66.26% -49.32% +3.76% +59.26% -40.77% +4.62% +27.89% -1.18% n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2014
Non-Us Revenue 78.64M 82.21M 91.79M 87.95M 87.52M 1.09B 190.81M 39.15M 32.51M
Non-Us Revenue Growth -4.35% -10.44% +4.37% +0.49% -91.98% +471.67% +387.42% +20.40% n/a
United States Revenue 11.48M 9.84M 10.11M 64.97M 27.09M n/a n/a n/a n/a
United States Revenue Growth +16.66% -2.70% -84.43% +139.79% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 18.96M 20.51M 20.15M 17.32M 21.15M 17.87M 21.08M 21.94M 22.53M 20.52M 27.34M 32.14M 29.47M 29.55M 31.68M 27.14M 26.98M 24.35M 26.22M 27.14M 23.98M 22.58M 25.01M 23.78M 18.72M 20.26M 18.69M 12.34M 12.05M 16.00M 11.98M 12.76M 10.25M 11.04M 10.23M 13.23M 9.54M 10.18M 10.30M
Selling, General, and Administrative Revenue Growth -7.57% +1.79% +16.33% -18.10% +18.34% -15.24% -3.91% -2.64% +9.81% -24.94% -14.94% +9.07% -0.29% -6.70% +16.74% +0.57% +10.82% -7.13% -3.41% +13.17% +6.21% -9.70% +5.17% +27.03% -7.62% +8.42% +51.47% +2.34% -24.64% +33.57% -6.14% +24.45% -7.09% +7.89% -22.72% +38.67% -6.28% -1.16% n/a
Research and Development Revenue 35.03M 29.72M 27.41M 29.94M 24.07M 29.68M 30.47M 34.74M 33.59M 42.74M 107.25M 99.61M 103.74M 101.31M 95.60M 102.72M 100.53M 96.44M 108.99M 110.37M 99.05M 106.69M 118.46M 108.88M 102.89M 88.33M 99.42M 81.43M 65.71M 60.26M 61.06M 50.23M 51.95M 52.35M 49.27M 47.13M 43.23M 45.41M 47.01M
Research and Development Revenue Growth +17.85% +8.45% -8.46% +24.40% -18.90% -2.59% -12.29% +3.42% -21.41% -60.15% +7.67% -3.98% +2.39% +5.97% -6.93% +2.18% +4.25% -11.52% -1.25% +11.43% -7.16% -9.94% +8.80% +5.82% +16.48% -11.15% +22.10% +23.91% +9.05% -1.31% +21.55% -3.31% -0.76% +6.26% +4.53% +9.04% -4.81% -3.40% n/a